Clinic
Sunrise Mountain View Hospital, INC.
Sunrise Mountain View Hospital, INC. was paid $770K by Medicaid between Jun 2023 and Dec 2024, across 53 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.
33Billing provider infoSUNRISE MOUNTAIN VIEW HOSPITAL, INC.
NORTH LAS VEGAS, NV 89084
NORTH LAS VEGAS, NV 89084
33aNPI1407405145assigned 09/05/2019
33bProvider typeEmergency Care Clinic/Center
28Total paid$770K
24GClaims27,227
24DCodes billed53
24AFirst – last monthJun 2023 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Nevada
Rank by total paid#3 of 11
Median peer was paid$305K
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 12,957 | $308K | |
| 2024incomplete | 14,270 | $461K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 41% | 4,106 | 3,081 | $313K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 1,985 | 1,442 | $132K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.3% | 1,012 | 743 | $71K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.4% | 376 | 283 | $41K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.2% | 479 | 343 | $40K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 1,214 | 881 | $35K |
| 80053 | Comprehensive metabolic panel | 2.3% | 1,524 | 1,150 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 626 | 497 | $17K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 559 | 408 | $16K |
| 87070 | 2.0% | 525 | 389 | $16K | |
| 83690 | 1.0% | 880 | 648 | $8K | |
| 81001 | <1% | 1,288 | 962 | $7K |
41 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 383 | $7K |
| 87430 | <1% | 596 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 285 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 568 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 621 | $3K |
| 85027 | <1% | 1,869 | $3K | |
| 81025 | <1% | 687 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 52 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 365 | $2K |
| 84484 | <1% | 487 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 784 | $2K |
| 93975 | <1% | 15 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 125 | $2K |
| 87420 | <1% | 65 | $2K | |
| 87088 | <1% | 48 | $1K | |
| 99285 | Emergency room visit (most serious) | <1% | 12 | $1K |
| 84703 | <1% | 493 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 125 | $981.54 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 117 | $957.20 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,071 | $943.15 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 38 | $788.50 |
| 83880 | <1% | 31 | $529.76 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,359 | $429.76 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $406.20 |
| 87210 | <1% | 17 | $292.46 | |
| 73630 | <1% | 14 | $149.76 | |
| 85730 | <1% | 91 | $143.50 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $141.36 |
| 85610 | <1% | 144 | $126.43 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 160 | $96.28 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 619 | $75.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 231 | $74.77 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 41 | $72.96 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 234 | $59.70 |
| 73130 | <1% | 12 | $52.20 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 96 | $33.37 |
| 81003 | <1% | 51 | $29.07 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 19 | $18.40 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 310 | $11.79 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 375 | $7.36 |
| S0028 | Injection, famotidine, 20 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKILLIAN, STEVE (CFO)
Parent organizationSUNRISE MOUNTAIN VIEW HOSPITAL, INC.
| Provider | Location | Paid |
|---|---|---|
| Sunrise Mountainview Hospital, INC. | Las Vegas, NV | $5.20M |
| Sunrise Mountainview Hospital, INC. | Las Vegas, NV | $75K |
| Sunrise Mountainview Hospital, INC. | Las Vegas, NV | $4.42 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.